Related Experiment Videos
Key issues in varicella-zoster virus latency.
1Department of Neurology, Glasgow University, and Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland, United Kingdom. P.G.Kennedy@clinmed.gla.ac.uk
Journal of Neurovirology
|December 20, 2002
Summary
Varicella-zoster virus (VZV) establishes latency in human ganglia, primarily in neurons. While gene expression is restricted during latency, further research is needed to fully understand VZV
Area of Science:
- Neurovirology
- Molecular Biology
- Immunology
Background:
- Varicella-zoster virus (VZV) causes chickenpox and shingles.
- VZV latency establishes in human trigeminal and spinal ganglia.
- Reactivation leads to herpes zoster (shingles).
Purpose of the Study:
- To elucidate the molecular mechanisms of VZV latency.
- To determine the cell-type localization of latent VZV.
- To define the nature and extent of VZV gene expression during latency.
Main Methods:
- Review of existing literature on VZV latency.
- Analysis of studies on VZV cell-type localization in ganglia.
- Examination of research on VZV gene expression during latency.
Main Results:
- Latent VZV is predominantly found in neuronal cells within human ganglia.
- VZV gene expression during latency is significantly restricted.
- At least four VZV genes are known to be expressed during latency, with potential for more.
Conclusions:
- VZV latency primarily involves neuronal cells in human ganglia.
- Understanding VZV gene expression during latency is crucial but incomplete.
- Future advances will rely on new molecular technologies and animal models.